2023 annual financial data
Intensity Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -8,319,000 USD and net income was -10,538,000 USD.
Operating cash flow was -7,205,000 USD.
Get free Intensity Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,319,000 USD
- Net income
- -10,538,000 USD
- Operating cash flow
- -7,205,000 USD